Resource Library
Our library of resources offers a wide variety of information on HIV prevention and care, capacity building and management, healthcare equity, and much more.
-
ICC COVID Immunization Dashboard
The recent changes in federal and state immunization policies for the 2025–2026 COVID-19 season have left many Americans uncertain about whether to get COVID-19 shots—and how to do so. To help navigate the current landscape in each state, the Immunocompromised Collaborative immunization dashboard from the Immune Deficiency Foundation tracks who is eligible for the 2025-2026 COVID-19 vaccine, as well as who can get it from a pharmacy without a prescription and whether state-regulated health insurance plans have to cover the cost.
-
MAPRx 2026 Open Enrollment Guide
The Annual Open Enrollment for Medicare prescription drug coverage (Part D) is October 15, 2025 – December 7, 2025 for coverage beginning January 1, 2026. Certain people with Medicare can also change plans at other times. Every year plans make changes to benefits and costs. With these different changes, your current plan may or may not be the best plan for you in 2026. This guide can help find answers to some important questions that can help you during the Annual Open Enrollment.
-
MAPRx MPPP Patient Guide for 2026
If your prescription drug costs are high, you may benefit from participating in the Medicare Prescription Payment Plan, also known as MPPP. This guide from Medicare Access for Patients Rx describes the Medicare Prescription Payment Plan and helps patients decide if it is right for them.
-
HealthHIV State of HIV Care™ Sixth Annual National Survey
HealthHIV’s Sixth Annual State of HIV Care™ National Survey identifies barriers that HIV care providers face in delivering care, captures their perspectives on existing resources, and highlights their experiences with achieving patient outcomes in 2024.
-
HealthHIV State of Aging with HIV™ Fourth Annual National Survey
This comprehensive national survey further underscores the ongoing needs and experiences of people aging, thriving, and sometimes struggling with the HIV; many of whom are among the first generation of people diagnosed with HIV.
-
Highlights from the Fourth Annual State of Aging with HIV Survey
Now in its fourth year, this national survey captures the experiences of people aging with HIV (PAWH) and the professionals who support them.
-
People on HIV drugs have ‘substantial’ Alzheimer’s protection: study
People taking drugs for HIV and hepatitis B are less likely to develop Alzheimer’s disease, according to a new study. UVA Health investigators now would like clinical trials to examine the potential of the HIV medications as a means to prevent Alzheimer’s disease.
-
NIAID HIV Language Guide
This guide includes language suggestions for communicating about HIV and related topics.
-
Patients With HIV May Have High Prevalence of Long COVID
The prevalence of long COVID was high in patients living with HIV, according to a review published in eClinicalMedicine.
-
Recommendations for Incorporating Geriatrics Into HIV Care Include Attention to Both Body and Mind
Of the nearly 1.1 million people living with HIV in the United States in 2022, an estimated 54% were over 50 years old, according to the Centers for Disease Control and Prevention (CDC). Yet we are not doing enough to meet the needs of this population: A recent CDC study found that the country was on pace to miss all of its 2025 goals for improving the quality of life for people living with HIV age 50 and older.
-
Nearly 20% of New HIV Diagnoses Occur Among Older Adults
Patients aged 50 and older who were newly diagnosed with HIV often reported heterosexual transmission and were more often women when compared with those younger than 50, according to an analysis of patients in New York State that was published in JAIDS.
-
HIV Prevention Protocols for Providers
This quick guide to HIV Prevention protocols includes CDC guidance on indications for PrEP recommendation, eligibility, evaluation, and prescribing information.
-
Pre-Exposure Prophylaxis (PrEP) Myths and Urban Legends
This list of commonly held myths and urban legends about PrEP provides starting points for discussions with patients.
-
Aging with HIV: Understanding the Journey
Join Gilead Sciences and the American Society on Aging for a series of podcast conversations about caring for older adults living with HIV.
-
DC Engage 3rd Annual Harm Reduction Conference
This recorded conference content was originally presented at the 3rd annual DC Engage Harm Reduction Conference in Washington, DC. Review the content at your own pace.
-
REINFORCE Resource Guide
This Resource Guide was developed as part of the HealthHIV REINFORCE initiative supporting five healthcare organizations to increase their retention and re-engagement in HIV care rates. These sites, situated around the country, ranged from large multi-site hospitals and health centers to small community-based organizations.
-
Resource Guide: HIV/HCV Health and Housing Collaborative
HealthHIV’s HIV/HCV Health and Housing’s 2023 Resource Guide was developed throughout a year-long technical assistance project with eight organizations working to increase their HIV/HCV screening and care capacity for their clients experiencing homelessness. The resources in this document provide insight into HIV/HCV care for people experiencing homelessness in a variety of settings and with a variety of populations.
-
PDAB Action Steps for Patients
Patients looking to contribute to the conversation about drug affordability and Upper Payment Limits (UPLs) can start here.
-
PDAB: Balancing the Scale
The Role of PDABs in Drug Pricing and Healthcare Stakeholder Impacts
-
Considerations and Implications of PDABs and Their Impact on 340Bs
Prescription Drug Affordability Boards (PDABs) are designed to help reduce the costs of prescription medications in 11 states where they currently exist (legislation pending in 13 more states).
-
Prescription Drug Affordability Boards (PDABs) and Upper Payment Limits (UPLs) Impact on Patients, Drug Pricing, and Innovation
This HealthHIV Advocacy paper explores the function of Prescription Drug Affordability Boards (PDABs) in managing prescription drug costs, considering perspectives of patients, providers, and payers to ensure equitable access to vital medications while controlling healthcare expenses.
-
Putting the Brakes on Accelerated Aging of Bone, Muscle from HIV Infection, Treatment
Antiretroviral cocktails can make human immunodeficiency virus, or HIV, undetectable and untransmittable, but both the virus and its treatment can also accelerate aging of bone and muscle.
